Deep knowledge on
small-molecule drugs and
the 110,000 global patents
Manage your formulary budget
Find generic entry opportunities
Anticipate generic drug launch
Proactively manage your pharmacy inventory
Drug patents …
… from Kazakhstan to Kalamazoo
Flat-rate pricing for predictable budgeting
Short-term plans for project- or client-based billing
Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
|Title:||Stable oral CI-981 formulation and process for preparing same|
|Abstract:||An oral pharmaceutical composition is provided for treating hypercholestereolemia or hyperlipidemia containing an advantageous formulation for stabilizing the HMG-CoA coenzyme A inhibitor, CI-981 Hemi-Calcium, of formula (IA) ##STR1## with effective amounts of calcium carbonate. A method for preparing a CI-981 stabilizing composition is described.|
|Inventor(s):||Mills; Nancy (Mt. Arlington, NJ), Muhammad; Nouman A. (Long Valley, NJ), Weiss; Jay (East Brunswick, NJ), Nesbitt; Russell U. (Somerville, NJ)|
|Assignee:||Warner-Lambert Company (Morris Plains, NJ)|
Patent Claim Types:|
see list of patent claims
|Use; Composition; Compound; Dosage form;|
Field: Not categorized
Back Citations: 4th percentile
Forward Citations: 1st percentile
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
|Canada||2150372||<disabled in preview>|
|Cyprus||2128||<disabled in preview>|
|Germany||69324504||<disabled in preview>|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.